Quick search:
| Result | Content | Outlet | Published | Research |
|---|---|---|---|---|
| Result | Content | Outlet | Published | Research |
| 1 | Tow Foundation Commits $2 Million to Multiple Myeloma Research at Sylvester | InventUM | University of Miami Miller School of Medicine | 19 days ago | |
| 2 | A Case of Newly Diagnosed Multiple Myeloma | Targeted Oncology | 7 days ago | |
| 3 | Arcellx Announces Dosing of First Patient in its Phase 1 Clinical Trial Evaluating ACLX-001, the First Therapeutic in the Dosable and Controllable ARC-SparX Platform, for the treatment of Patients with Relapsed or Refractory Multiple Myeloma | Yahoo Finance | 6 days ago | |
| 4 | New Chief of Bone Marrow Transplant and Cellular Therapies Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center | Newswise | 25 days ago | |
| 5 | CAR-T therapy effective in Black and Hispanic patients | Science Daily | 18 days ago | |
| 6 | Starton Therapeutics Provides Update on STAR-LLD Lenalidomide Clinical Program | GlobeNewswire | 12 days ago | |
| 7 | ORIC Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update | The Bakersfield Californian | 7 days ago | |
| 8 | Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2022 | Yahoo Finance | 4 days ago | |
| 9 | Real-World Data Confirm Lack of Standard Care for Triple-Exposed Multiple Myeloma | Cancer Therapy Advisor | 18 days ago | |
| 10 | International Myeloma Foundation Welcomes Fatima Scipione as Senior Vice President of Strategic Alliances and External Affairs | Yahoo Finance | 4 days ago | |
| 11 | How to manage multiple myeloma pain in the body | Medical News Today | 25 days ago | |
| 12 | Cilta-Cel Induces Impressive ORR in Relapsed/Refractory Multiple Myeloma | OncLive | 13 days ago | |
| 13 | Medical Minute: OhioHealth Blood and Marrow Transplant Program | OhioHealth Newsroom | 28 days ago | |
| 14 | VRd for multiple myeloma: Uses and side effects | Medical News Today | 20 days ago | |
| 15 | iTeos Reports First Quarter 2022 Financial Results and Provides Business Update | GlobeNewswire | 4 days ago | |
| 16 | Dr. Lin on Treatment Updates in CAR T-Cell Therapy in Myeloma | OncLive | 25 days ago | |
| 17 | Roswell Park Specialists to Highlight Latest Advances in Blood Cancer Treatment and Cellular Therapy | Newswise | 23 days ago | |
| 18 | Episode 2: Frontline Therapy for Multiple Myeloma | Medscape | 13 days ago | |
| 19 | Fresenius Kabi Introduces New Generic for the Treatment of Multiple Myeloma | Business Wire | 14 days ago | |
| 20 | Multiple Myeloma is Being Diagnosed More Often in Younger Patients, But The Reasons Why Are Unclear | Curetoday.com | 2 months ago | |
| 21 | Roche's TIGIT flop prompts GSK, iTeos to reevaluate next steps for rival drug | FierceBiotech | 3 days ago | |
| 22 | Caribou Biosciences Reports First Quarter 2022 Financial Results and Provides Business Updates | Yahoo Finance | 7 days ago | |
| 23 | Educated Patient® Multiple Myeloma Summit Upcoming FDA Approvals Presentation: March 12, 2022 | Curetoday.com | 1 month ago | |
| 24 | Allogene Therapeutics Receives FDA Orphan-Drug Designation for ALLO-605, its First TurboCAR™ T Cell Product Candidate, for the Treatment of Multiple Myeloma | BioSpace | 19 days ago | |
| 25 | UCSF Showcases Potentially Game-Changing Trials Across Multiple Myeloma Settings | OncLive | 3 months ago | |
| 26 | ESPN's Dave Flemming Salutes Colleague Rod Gilmore, John Saunders Award Recipient At The Dick Vitale Gala Tonight | espnfrontrow.com | 10 days ago | |
| 27 | MiNK Therapeutics Corporate Update and First Quarter 2022 Financial Report | Yahoo Finance | 6 days ago | |
| 28 | Ace the Case: A 68-Year-Old Woman With Smoldering Multiple Myeloma | Healio | 1 month ago | |
| 29 | Smilow Multiple Myeloma and Gammopathies Program < Yale School of Medicine | Yale School of Medicine | 1 year ago | |
| 30 | Moving Mountains for Multiple Myeloma | Curetoday.com | 2 months ago | |
| 31 | Optimizing Therapy in Frontline Multiple Myeloma Not Eligible for Transplant | Cancer Network | 5 months ago | |
| 32 | The Melanoma Research Alliance Names Dr. Marc Hurlbert as Chief Executive Officer | Business Wire | 4 days ago | |
| 33 | Moving Mountains for Multiple Myeloma Program to Hike Through Alaska's Kenai Peninsula-Glaciers, Coastline & Wildlife in August | Curetoday.com | 9 months ago | |
| 34 | Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medicines and Significant Progress in Treating Earlier Stages of Certain Cancers With KEYTRUDA® (pembrolizumab) | Merck | 6 days ago | |
| 35 | Dr. Gerald A. 'Jerry' Glowacki, a retired OB-GYN and former department chair at MedStar Franklin Square Medical Center, dies | Baltimore Sun | 4 days ago | |
| 36 | Recap: Improving Outcomes in Newly Diagnosed Multiple Myeloma | Cancer Network | 4 months ago | |
| 37 | Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated Milestones | GlobeNewswire | 7 days ago | |
| 38 | Multiple myeloma specialist named inaugural director of blood cancer center | Healio | 3 months ago | |
| 39 | NCI Cancer Currents Blog: Perlmutter Cancer Center Medical Oncologist Discusses New Treatment for Multiple Myeloma | NYU Langone Health | 2 months ago | |
| 40 | Perlmutter Cancer Center Appoints Inaugural Director of Center for Blood Cancers | NYU Langone Health | 4 months ago | |
| 41 | Multiple Myeloma Symptoms & Treatment in NJ | RWJBarnabas Health | 4 months ago | |
| 42 | CORRECTION | Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business Highlights | 11 days ago | |
| 43 | A Glimpse Into the Future of Myeloma Patient Management | Healio | 4 months ago | |
| 44 | Myeloma Research at Dana-Farber Advances With $40M Foundation Givt | Myeloma Research News | 4 months ago | |
| 45 | Paying It Forward for Other Patients With Multiple Myeloma | Curetoday.com | 7 months ago | |
| 46 | Gamida Cell Reports First Quarter 2022 Financial Results and Provides Company Update | Business Wire | 6 days ago | |
| 47 | Cellectis Provides Business Update and Reports Financial Results for First Quarter 2022 | KULR-TV | 4 days ago | |
| 48 | Multiple Myeloma Landscape Grows At Rapid Pace With Quadruplets and BCMA-Directed Therapy | OncLive | 3 months ago | |
| 49 | Survivor on a mission to raise awareness about multiple myeloma, address health disparities | Medical University of South Carolina | 2 months ago | |
| 50 | Checkmate details troubled future if Regeneron's $250M buy fails | FierceBiotech | 3 days ago | |
| 51 | GSK showcases progress from the DREAMM clinical trial program in multiple myeloma at the 2021 ASH Annual Meeting | PR Newswire | 6 months ago | |
| 52 | FDA tags Editas' thalassemia cell therapy an orphan drug as it rounds final bend in race to clinic | FierceBiotech | 3 days ago | |
| 53 | Jakubowiak on Future Promise of Cilta-Cel Across Settings in Multiple Myeloma at 2021 ASH | Cancer Network | 4 months ago | |
| 54 | How One Woman Used Her Multiple Myeloma Diagnosis to Fuel the Search for a Cure | Health.com | 4 months ago | |
| 55 | Full Show: Engineered Toxin Bodies Targeting CD38 in Myeloma with Shaji Kumar, MD, Mayo Clinic | Myeloma Crowd News | 4 months ago | |
| 56 | A Phase IB Study of Teclistamab with Other Treatments in People with Multiple Myeloma | On Cancer | 3 months ago | |
| 57 | BioLineRx Reports First Quarter 2022 Financial Results and Provides Corporate Update USA | English | 5 days ago | |
| 58 | Multiple Myeloma Awareness | Spectrum News | 3 months ago | |
| 59 | Socioeconomic Gaps Can Lead to Poorer Outcomes in Multiple Myeloma | Curetoday.com | 2 months ago | |
| 60 | Robert’s Story: CAR T Cell Therapy Offers New Hope for Multiple Myeloma | On Cancer | 12 months ago | |
| 61 | Living with multiple myeloma during the era of Covid | Palm Beach Post | 6 months ago | |
| 62 | A Phase I/II Study of CFT7455 in People with Non-Hodgkin Lymphoma or Multiple Myeloma | On Cancer | 4 months ago | |
| 63 | Backed by Strong Survival, Janssen Submits BLA for Multiple Myeloma Drug | BioSpace | 5 months ago | |
| 64 | Multiple Myeloma | Chicago Health | 2 months ago | |
| 65 | GSK crowdsources multiple myeloma innovation in new program | Medical Marketing and Media | 4 months ago | |
| 66 | The MMRF: Understanding and Sharing the Genomic Landscape of Multiple Myeloma | AJMC.com Managed Markets Network | 5 months ago | |
| 67 | First Allogeneic RNA Cell Therapy Clinical Trial Begins in Multiple Myeloma | Curetoday.com | 4 months ago | |
| 68 | MOLECULAR TEMPLATES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) | Marketscreener.com | 3 days ago | |
| 69 | Thomas G. Martin, MD, Discusses Approval of Cilta-Cel in R/R Multiple Myeloma | Cancer Network | 2 months ago | |
| 70 | Scientists Identify New Types of a Blood Cancer and Potential Targeted Treatments | Mount Sinai | 6 months ago | |
| 71 | Myeloma at MD Anderson: Watch the MCRT in Houston Online on March 26 | Myeloma Crowd News | 2 months ago | |
| 72 | Miami Cancer Institute Launches Two FDA-Approved Clinical Trials for Patients with Blood Cancers Who Undergo Stem Cell Transplantation | Baptist Health South Florida | 2 months ago | |
| 73 | New Blood Tests Reduce Need for Bone Marrow Biopsy in Multiple Myeloma | Targeted Oncology | 2 months ago | |
| 74 | UCSF's Dr Thomas Martin Discusses Quadruplets vs Triplets in Multiple Myeloma | AJMC.com Managed Markets Network | 7 months ago | |
| 75 | Takeda previews early response data for 'Wave 2' multiple myeloma med in follow-up to Velcade | FierceBiotech | 5 months ago | |
| 76 | CASI Pharmaceuticals, Inc.'s (CASI) CEO Wei-Wu He on Q1 2022 Results | Earnings Call Transcript | 4 days ago | |
| 77 | Six Steps for Newly Diagnosed Multiple Myeloma Patients | Myeloma Crowd News | 2 months ago | |
| 78 | How Can Multiple Myeloma Affect a Patient's Lifestyle? | Cancer Therapy Advisor | 2 months ago | |
| 79 | Treatment With Cilta-Cel Continues Yield Robust, Long-Lasting Outcomes in Relapsed/Refractory Multiple Myeloma | Cancer Network | 5 months ago | |
| 80 | Depression and Anxiety Shown to Deter Patients With Cancer From Joining Clinical Trials | Curetoday.com | 2 months ago | |
| 81 | How Does Multiple Myeloma Affect COVID-19 Vaccines? | Curetoday.com | 2 months ago | |
| 82 | New Data from MajesTEC-1 Study Show Continued Deep and Durable Responses of Teclistamab (BCMAxCD3 Bispecific Antibody) in Treatment of Heavily Pretreated Patients with Multiple Myeloma | PR Newswire | 5 months ago | |
| 83 | Poseida Therapeutics Provides Update on BCMA-Targeted CAR-T Clinical Trials at the 2021 American Society of Hematology (ASH) Annual Meeting | Yahoo Finance | 5 months ago | |
| 84 | Precision BioSciences Reports First Quarter 2022 Financial Results and Provides Business Update | Business Wire | 7 days ago | |
| 85 | Challenges in Treating Transplant-Ineligible Multiple Myeloma | Cancer Network | 8 months ago | |
| 86 | A Phase III Study Comparing JNJ-68284528 CAR T-Cell Therapy with a Combination of Standard Medical Treatments in Patients with Recurrent or Persistent Multiple Myeloma | On Cancer | 3 months ago | |
| 87 | Why It's Important to Collaborate Through Communication in Myeloma | Curetoday.com | 2 months ago | |
| 88 | Feasibility of a Digital Life Coaching Intervention for Patients Undergoing SCT for Multiple Myeloma | Oncology Nurse Advisor | 4 months ago | |
| 89 | Legend Biotech to Host Hybrid KOL Event Detailing CARTITUDE Data from the 63rd American Society of Hematology (ASH) Annual Meeting | Yahoo Finance | 5 months ago | |
| 90 | ONCONOVA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) | Marketscreener.com | 3 days ago | |
| 91 | GSK unveils Target the Future, a global, multi-year program to help address key challenges affecting the multiple myeloma community | PR Newswire | 6 months ago | |
| 92 | Compugen Presents New Research Suggesting Targeting DNAM-1 Axis Holds Promise for Treatment of Multiple Myeloma | Yahoo Finance | 2 months ago | |
| 93 | Clinical Case 1: 69-Year-Old Man With Multiple Myeloma (MM) | OncLive | 5 months ago | |
| 94 | CAR-T Cell Therapy May Have 'Big Future' in Relapsed/ Refractory Multiple Myeloma | Curetoday.com | 2 months ago | |
| 95 | Ace the Case: 71-Year-Old Woman With IgG Lambda Multiple Myeloma at Third Relapse | Healio | 3 months ago | |
| 96 | Treating Bone Pain in Multiple Myeloma | Curetoday.com | 2 months ago | |
| 97 | Sanofi announces €300 million collaboration with Blackstone Life Sciences to advance an innovative treatment for multiple myeloma | BioSpace | 2 months ago | |
| 98 | Triplet and Quadruplet Induction Regimens for Transplant-Eligible NDMM: Focus on GRIFFIN and MASTER Trials | Cancer Network | 2 months ago | |
| 99 | Molecular Templates, Inc. Reports First Quarter 2022 Financial Results | GlobeNewswire | 4 days ago | |
| 100 | Dr. Martin on Key Advances in Multiple Myeloma | OncLive | 9 months ago |